7TI0

Structure of CTX-M-15 bound to RPX-7063 at 1.5A

• PDB DOI: https://doi.org/10.2210/pdb7TI0/pdb

• Classification: HYDROLASE
• Organism(s): Klebsiella pneumoniae
• Expression System: Escherichia coli
• Mutation(s): No 


• Deposited: 2022-01-12 Released: 2022-05-18 
• Deposition Author(s): Clifton, M.C., Abendroth, J., Hecker, S.J., Edwards, T.E.
• Funding Organization(s): Other private

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 1.50 Å
• R-Value Free: 0.178 
• R-Value Work: 0.160 
• R-Value Observed: 0.160 

Literature

Broad-spectrum cyclic boronate beta-lactamase inhibitors featuring an intramolecular prodrug for oral bioavailability.

Reddy, K.R., Totrov, M., Lomovskaya, O., Griffith, D.C., Tarazi, Z., Clifton, M.C., Hecker, S.J.

(2022) Bioorg Med Chem 62: 116722-116722

• PubMed: 35358864 
• DOI: https://doi.org/10.1016/j.bmc.2022.116722
• Primary Citation of Related Structures:  
  7TI0, 7TI1, 7TI2


• PubMed Abstract: 
  

  Early efforts to broaden the spectrum and potency of cyclic boronic acid β-lactamase inhibitor vaborbactam included a series of 7-membered ring boronates. Exploration of stereoisomers and incorporation of heteroatoms allowed identification of the all-carbon cyclic boronate with substituents trans as the preferred core structure, showing inhibition of Class A and C enzymes. Crystal structures of one analog bound to important β-lactamase enzymes were obtained. When isolated under acidic conditions, these compounds spontaneously formed a neutral cyclic anhydride (intramolecular prodrug) which was shown to have much-improved oral bioavailability (52-69%) compared to the ring-opened carboxylate salt (9%).

---

Organizational Affiliation: 

Qpex Biopharma, Inc, 6275 Nancy Ridge Dr., Suite 100, San Diego, CA 92121, United States.

Biological Assembly 1  

Global Symmetry: Asymmetric - C1 
Global Stoichiometry: Monomer - A1 

Biological assembly 1 assigned by authors.

Biological Assembly Evidence: homology

Macromolecule Content

• Total Structure Weight: 28.74 kDa 
• Atom Count: 2,265 
• Modelled Residue Count: 260 
• Deposited Residue Count: 263 
• Unique protein chains: 1

Macromolecules

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
Beta-lactamase	A	263	Klebsiella pneumoniae	Mutation(s): 0  Gene Names: blaCTX-M-15, bla_1, bla_10, bla_2, bla_3, blaCTX-M, CTX-M, CTX-M-15 EC: 3.5.2.6
UniProt
Find proteins for Q2PUH3 (Klebsiella pneumoniae) Explore Q2PUH3  Go to UniProtKB:  Q2PUH3

Small Molecules

Ligands 4 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram
ZXQ (Subject of Investigation/LOI)	B [auth A]	{(3R,7S)-2-hydroxy-3-[2-(thiophen-2-yl)acetamido]-2,3,4,7-tetrahydro-1,2-oxaborepin-7-yl}acetic acid C13 H16 B N O5 S JQVILEFLUQMOSI-KOLCDFICSA-N
SO4	C [auth A], D [auth A]	SULFATE ION O4 S QAOWNCQODCNURD-UHFFFAOYSA-L
EDO	E [auth A]	1,2-ETHANEDIOL C2 H6 O2 LYCAIKOWRPUZTN-UHFFFAOYSA-N
CL	F [auth A]	CHLORIDE ION Cl VEXZGXHMUGYJMC-UHFFFAOYSA-M

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 1.50 Å
• R-Value Free: 0.178 
• R-Value Work: 0.160 
• R-Value Observed: 0.160 
• Space Group: P 2₁ 2₁ 2₁

Unit Cell:

Length ( Å )	Angle ( ˚ )
a = 45.88	α = 90
b = 44.78	β = 90
c = 117.19	γ = 90

Software Package:

Software Name	Purpose
REFMAC	refinement
PDB_EXTRACT	data extraction
XDS	data reduction
XSCALE	data scaling
PHASER	phasing

Structure Validation

Entry History & Funding Information

Deposition Data

• Released Date: 2022-05-18 
Deposition Author(s): Clifton, M.C., Abendroth, J., Hecker, S.J., Edwards, T.E.

---

Funding Organization	Location	Grant Number
Other private		--

Revision History  

• Version 1.0: 2022-05-18
  Type: Initial release
  
• Version 1.1: 2023-10-18
  Changes: Data collection, Refinement description